Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer
- 20 May 2020
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 319 (2), C233-C243
- https://doi.org/10.1152/ajpcell.00079.2020
Abstract
Pancreatic ductal adenocarcinoma (PDA) is a devastating disease with a poor survival rate. It is resistant to therapy in part due to its unique tumor microenvironment, characterized by a desmoplastic reaction resulting in a dense stroma that constitutes a large fraction of the tumor volume. A major contributor to the desmoplastic reaction is cancer-associated fibroblasts (CAFs). CAFs actively interact with cancer cells and promote tumor progression by different mechanisms, including extracellular matrix deposition, remodeling, and the secretion of tumor promoting factors, making CAFs an attractive target for PDA. However, emerging evidences indicate significant tumor-suppressive functions of CAFs, highlighting the complexity of CAF biology. CAFs were once considered as a uniform cell type within the cancer stroma. Recently, the existence of CAF heterogeneity in PDA has become appreciated. Due to advances in single cell technology, distinct subtypes of CAFs have been identified in PDA. Here we review recent updates in CAF biology in PDA, which may help develop effective CAF-targeted therapies in the future.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (CA192381, CA210181)
- Effie Marie Cain Fellowship (na)
- Jean Shelby Fund for Cancer Research at Communities Foundation of Texas (na)
This publication has 127 references indexed in Scilit:
- Three-Dimensional Collagen I Promotes Gemcitabine Resistance In Vitro in Pancreatic Cancer Cells through HMGA2-Dependent Histone Acetyltransferase ExpressionPLOS ONE, 2013
- Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculatureNature, 2012
- Fibrocytes: emerging effector cells in chronic inflammationNature Reviews Immunology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancerThe Journal of Experimental Medicine, 2011
- Human Gingiva-Derived Mesenchymal Stem Cells Elicit Polarization of M2 Macrophages and Enhance Cutaneous Wound HealingThe International Journal of Cell Cloning, 2010
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progressionTrends in Immunology, 2010
- CD4+T cells control the differentiation of Gr1+monocytes into fibrocytesProceedings of the National Academy of Sciences of the United States of America, 2009
- CXCL8/IL‐8 and CXCL12/SDF‐1α co‐operatively promote invasiveness and angiogenesis in pancreatic cancerInternational Journal of Cancer, 2008
- Collagen I–mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1The Journal of cell biology, 2008